Security & Protection Services
Compare Stocks
5 / 10Stock Comparison
GFAI vs ARMK vs BCO vs TRMK vs ABM
Revenue, margins, valuation, and 5-year total return — side by side.
Specialty Business Services
Security & Protection Services
Banks - Regional
Specialty Business Services
GFAI vs ARMK vs BCO vs TRMK vs ABM — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Security & Protection Services | Specialty Business Services | Security & Protection Services | Banks - Regional | Specialty Business Services |
| Market Cap | $10M | $11.84B | $4.44B | $2.64B | $2.39B |
| Revenue (TTM) | $72M | $18.79B | $5.39B | $1.12B | $8.87B |
| Net Income (TTM) | $-24M | $317M | $180M | $224M | $158M |
| Gross Margin | 15.1% | 7.0% | 26.1% | 71.0% | 11.5% |
| Operating Margin | -27.4% | 4.2% | 10.7% | 25.5% | 3.7% |
| Forward P/E | — | 20.3x | 11.6x | 11.5x | 10.2x |
| Total Debt | $3M | $5.72B | $4.93B | $1.12B | $1.69B |
| Cash & Equiv. | $22M | $639M | $2.27B | $668M | $104M |
GFAI vs ARMK vs BCO vs TRMK vs ABM — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | Jan 21 | May 26 | Return |
|---|---|---|---|
| Guardforce AI Co., … (GFAI) | 100 | 0.5 | -99.5% |
| Aramark (ARMK) | 100 | 182.1 | +82.1% |
| The Brink's Company (BCO) | 100 | 157.4 | +57.4% |
| Trustmark Corporati… (TRMK) | 100 | 162.8 | +62.8% |
| ABM Industries Inco… (ABM) | 100 | 109.4 | +9.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: GFAI vs ARMK vs BCO vs TRMK vs ABM
Each card shows where this stock fits in a portfolio — not just who wins on paper.
GFAI lags the leaders in this set but could rank higher in a more targeted comparison.
ARMK ranks third and is worth considering specifically for growth exposure and sleep-well-at-night.
- Rev growth 6.4%, EPS growth 23.2%, 3Y rev CAGR 10.6%
- Lower volatility, beta 0.71, current ratio 0.99x
- Beta 0.71 vs GFAI's 2.31
BCO is the clearest fit if your priority is long-term compounding.
- 293.0% 10Y total return vs TRMK's 127.7%
TRMK carries the broadest edge in this set and is the clearest fit for growth and quality.
- 34.8% NII/revenue growth vs GFAI's 0.2%
- 20.0% margin vs GFAI's -32.9%
- +32.5% vs GFAI's -53.2%
ABM is the #2 pick in this set and the best alternative if income & stability and valuation efficiency is your priority.
- Dividend streak 36 yrs, beta 0.72, yield 2.6%
- PEG 0.04 vs TRMK's 1.42
- Beta 0.72, yield 2.6%, current ratio 1.48x
- Lower P/E (10.2x vs 11.5x), PEG 0.04 vs 1.42
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 34.8% NII/revenue growth vs GFAI's 0.2% | |
| Value | Lower P/E (10.2x vs 11.5x), PEG 0.04 vs 1.42 | |
| Quality / Margins | 20.0% margin vs GFAI's -32.9% | |
| Stability / Safety | Beta 0.71 vs GFAI's 2.31 | |
| Dividends | 2.6% yield, 36-year raise streak, vs BCO's 0.9%, (1 stock pays no dividend) | |
| Momentum (1Y) | +32.5% vs GFAI's -53.2% | |
| Efficiency (ROA) | 3.0% ROA vs GFAI's -50.2%, ROIC 7.5% vs -41.6% |
GFAI vs ARMK vs BCO vs TRMK vs ABM — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
Segment breakdown not available.
GFAI vs ARMK vs BCO vs TRMK vs ABM — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
TRMK leads in 2 of 6 categories
ABM leads 2 • BCO leads 1 • GFAI leads 0 • ARMK leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
TRMK leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ARMK is the larger business by revenue, generating $18.8B annually — 259.4x GFAI's $72M. TRMK is the more profitable business, keeping 20.0% of every revenue dollar as net income compared to GFAI's -32.9%. On growth, BCO holds the edge at +10.3% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $72M | $18.8B | $5.4B | $1.1B | $8.9B |
| EBITDAEarnings before interest/tax | -$12M | $1.3B | $797M | $323M | $431M |
| Net IncomeAfter-tax profit | -$24M | $317M | $180M | $224M | $158M |
| Free Cash FlowCash after capex | -$6M | $257M | $544M | $230M | $327M |
| Gross MarginGross profit ÷ Revenue | +15.1% | +7.0% | +26.1% | +71.0% | +11.5% |
| Operating MarginEBIT ÷ Revenue | -27.4% | +4.2% | +10.7% | +25.5% | +3.7% |
| Net MarginNet income ÷ Revenue | -32.9% | +1.7% | +3.3% | +20.0% | +1.8% |
| FCF MarginFCF ÷ Revenue | -8.8% | +1.4% | +10.1% | +20.7% | +3.7% |
| Rev. Growth (YoY)Latest quarter vs prior year | +3.6% | +6.1% | +10.3% | — | +6.1% |
| EPS Growth (YoY)Latest quarter vs prior year | +38.9% | -7.7% | -35.3% | +5.4% | -7.2% |
Valuation Metrics
ABM leads this category, winning 3 of 7 comparable metrics.
Valuation Metrics
At 12.1x trailing earnings, TRMK trades at a 67% valuation discount to ARMK's 36.9x P/E. Adjusting for growth (PEG ratio), ABM offers better value at 0.05x vs TRMK's 1.50x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $10M | $11.8B | $4.4B | $2.6B | $2.4B |
| Enterprise ValueMkt cap + debt − cash | -$9M | $16.9B | $7.1B | $3.1B | $4.0B |
| Trailing P/EPrice ÷ TTM EPS | -0.89x | 36.93x | 22.93x | 12.13x | 15.74x |
| Forward P/EPrice ÷ next-FY EPS est. | — | 20.27x | 11.58x | 11.45x | 10.15x |
| PEG RatioP/E ÷ EPS growth rate | — | — | 0.38x | 1.50x | 0.05x |
| EV / EBITDAEnterprise value multiple | — | 13.35x | 8.01x | 9.49x | 9.23x |
| Price / SalesMarket cap ÷ Revenue | 0.28x | 0.64x | 0.84x | 2.36x | 0.27x |
| Price / BookPrice ÷ Book value/share | 0.16x | 3.81x | 11.14x | 1.28x | 1.43x |
| Price / FCFMarket cap ÷ FCF | — | 26.06x | 10.17x | 11.39x | 15.40x |
Profitability & Efficiency
BCO leads this category, winning 4 of 9 comparable metrics.
Profitability & Efficiency
BCO delivers a 45.6% return on equity — every $100 of shareholder capital generates $46 in annual profit, vs $-70 for GFAI. GFAI carries lower financial leverage with a 0.08x debt-to-equity ratio, signaling a more conservative balance sheet compared to BCO's 12.10x. On the Piotroski fundamental quality scale (0–9), ARMK scores 7/9 vs ABM's 6/9, reflecting strong financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -69.7% | +9.8% | +45.6% | +10.8% | +8.8% |
| ROA (TTM)Return on assets | -50.2% | +2.4% | +2.5% | +1.2% | +3.0% |
| ROICReturn on invested capital | -41.6% | +7.3% | +14.3% | +7.1% | +7.5% |
| ROCEReturn on capital employed | -19.1% | +8.7% | +12.1% | +3.2% | +8.2% |
| Piotroski ScoreFundamental quality 0–9 | 6 | 7 | 6 | 7 | 6 |
| Debt / EquityFinancial leverage | 0.08x | 1.81x | 12.10x | 0.53x | 0.95x |
| Net DebtTotal debt minus cash | -$19M | $5.1B | $2.7B | $448M | $1.6B |
| Cash & Equiv.Liquid assets | $22M | $639M | $2.3B | $668M | $104M |
| Total DebtShort + long-term debt | $3M | $5.7B | $4.9B | $1.1B | $1.7B |
| Interest CoverageEBIT ÷ Interest expense | -167.24x | 2.20x | 3.90x | 0.75x | 3.25x |
Total Returns (Dividends Reinvested)
TRMK leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in ARMK five years ago would be worth $17,052 today (with dividends reinvested), compared to $46 for GFAI. Over the past 12 months, TRMK leads with a +32.5% total return vs GFAI's -53.2%. The 3-year compound annual growth rate (CAGR) favors TRMK at 29.8% vs GFAI's -60.4% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -26.3% | +23.5% | -7.3% | +15.5% | -3.1% |
| 1-Year ReturnPast 12 months | -53.2% | +19.0% | +19.4% | +32.5% | -16.0% |
| 3-Year ReturnCumulative with dividends | -93.8% | +87.4% | +75.3% | +118.5% | +3.4% |
| 5-Year ReturnCumulative with dividends | -99.5% | +70.5% | +39.3% | +47.6% | -14.1% |
| 10-Year ReturnCumulative with dividends | -99.5% | +97.1% | +293.0% | +127.7% | +48.7% |
| CAGR (3Y)Annualised 3-year return | -60.4% | +23.3% | +20.6% | +29.8% | +1.1% |
Risk & Volatility
Evenly matched — TRMK and ABM each lead in 1 of 2 comparable metrics.
Risk & Volatility
ARMK is the less volatile stock with a 0.71 beta — it tends to amplify market swings less than GFAI's 2.31 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. TRMK currently trades 97.6% from its 52-week high vs GFAI's 31.5% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.36x | 0.78x | 1.12x | 0.92x | 0.71x |
| 52-Week HighHighest price in past year | $1.50 | $46.88 | $136.37 | $45.99 | $52.94 |
| 52-Week LowLowest price in past year | $0.38 | $35.07 | $80.10 | $33.39 | $36.96 |
| % of 52W HighCurrent price vs 52-week peak | +31.5% | +96.1% | +79.0% | +97.6% | +77.0% |
| RSI (14)Momentum oscillator 0–100 | 47.0 | 62.0 | 52.0 | 56.0 | 54.8 |
| Avg Volume (50D)Average daily shares traded | 378K | 2.2M | 543K | 392K | 512K |
Analyst Outlook
ABM leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: ARMK as "Buy", BCO as "Buy", TRMK as "Hold", ABM as "Hold". Consensus price targets imply 51.3% upside for BCO (target: $163) vs 1.4% for TRMK (target: $46). For income investors, ABM offers the higher dividend yield at 2.57% vs ARMK's 0.92%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Buy | Buy | Hold | Hold |
| Price TargetConsensus 12-month target | — | $47.20 | $163.00 | $45.50 | $50.00 |
| # AnalystsCovering analysts | — | 24 | 9 | 9 | 11 |
| Dividend YieldAnnual dividend ÷ price | — | +0.9% | +0.9% | +2.2% | +2.6% |
| Dividend StreakConsecutive years of raises | — | 1 | 6 | 1 | 36 |
| Dividend / ShareAnnual DPS | — | $0.41 | $1.00 | $0.97 | $1.05 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +1.2% | +4.7% | +3.0% | +5.1% |
TRMK leads in 2 of 6 categories (Income & Cash Flow, Total Returns). ABM leads in 2 (Valuation Metrics, Analyst Outlook). 1 tied.
GFAI vs ARMK vs BCO vs TRMK vs ABM: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is GFAI or ARMK or BCO or TRMK or ABM a better buy right now?
For growth investors, Trustmark Corporation (TRMK) is the stronger pick with 34.
8% revenue growth year-over-year, versus 0. 2% for Guardforce AI Co. , Limited (GFAI). Trustmark Corporation (TRMK) offers the better valuation at 12. 1x trailing P/E (11. 5x forward), making it the more compelling value choice. Analysts rate Aramark (ARMK) a "Buy" — based on 24 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — GFAI or ARMK or BCO or TRMK or ABM?
On trailing P/E, Trustmark Corporation (TRMK) is the cheapest at 12.
1x versus Aramark at 36. 9x. On forward P/E, ABM Industries Incorporated is actually cheaper at 10. 2x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: ABM Industries Incorporated wins at 0. 04x versus Trustmark Corporation's 1. 42x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — GFAI or ARMK or BCO or TRMK or ABM?
Over the past 5 years, Aramark (ARMK) delivered a total return of +70.
5%, compared to -99. 5% for Guardforce AI Co. , Limited (GFAI). Over 10 years, the gap is even starker: BCO returned +291. 2% versus GFAI's -99. 5%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — GFAI or ARMK or BCO or TRMK or ABM?
By beta (market sensitivity over 5 years), ABM Industries Incorporated (ABM) is the lower-risk stock at 0.
71β versus Guardforce AI Co. , Limited's 2. 36β — meaning GFAI is approximately 231% more volatile than ABM relative to the S&P 500. On balance sheet safety, Guardforce AI Co. , Limited (GFAI) carries a lower debt/equity ratio of 8% versus 12% for The Brink's Company — giving it more financial flexibility in a downturn.
05Which is growing faster — GFAI or ARMK or BCO or TRMK or ABM?
By revenue growth (latest reported year), Trustmark Corporation (TRMK) is pulling ahead at 34.
8% versus 0. 2% for Guardforce AI Co. , Limited (GFAI). On earnings-per-share growth, the picture is similar: ABM Industries Incorporated grew EPS 102. 3% year-over-year, compared to 1. 9% for Trustmark Corporation. Over a 3-year CAGR, ARMK leads at 10. 6% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — GFAI or ARMK or BCO or TRMK or ABM?
Trustmark Corporation (TRMK) is the more profitable company, earning 20.
0% net margin versus -16. 1% for Guardforce AI Co. , Limited — meaning it keeps 20. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: TRMK leads at 25. 5% versus -18. 5% for GFAI. At the gross margin level — before operating expenses — TRMK leads at 71. 0%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is GFAI or ARMK or BCO or TRMK or ABM more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, ABM Industries Incorporated (ABM) is the more undervalued stock at a PEG of 0. 04x versus Trustmark Corporation's 1. 42x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, ABM Industries Incorporated (ABM) trades at 10. 2x forward P/E versus 20. 3x for Aramark — 10. 1x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for BCO: 51. 3% to $163. 00.
08Which pays a better dividend — GFAI or ARMK or BCO or TRMK or ABM?
In this comparison, ABM (2.
6% yield), TRMK (2. 2% yield), BCO (0. 9% yield), ARMK (0. 9% yield) pay a dividend. GFAI does not pay a meaningful dividend and should not be held primarily for income.
09Is GFAI or ARMK or BCO or TRMK or ABM better for a retirement portfolio?
For long-horizon retirement investors, ABM Industries Incorporated (ABM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
71), 2. 6% yield). Guardforce AI Co. , Limited (GFAI) carries a higher beta of 2. 36 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ABM: +47. 0%, GFAI: -99. 5%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between GFAI and ARMK and BCO and TRMK and ABM?
These companies operate in different sectors (GFAI (Industrials) and ARMK (Industrials) and BCO (Industrials) and TRMK (Financial Services) and ABM (Industrials)), which means they face different economic cycles, regulatory environments, and macro sensitivities — making direct comparison nuanced.
In terms of investment character: GFAI is a small-cap quality compounder stock; ARMK is a mid-cap quality compounder stock; BCO is a small-cap quality compounder stock; TRMK is a small-cap high-growth stock; ABM is a small-cap deep-value stock. ARMK, BCO, TRMK, ABM pay a dividend while GFAI does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.